Of note, previous studies have shown increased expression of NLRP3 inflammasome, IL-1β, and IL-18 in patients with CAD [90,91,92], suggesting a role of such mechanisms in atherogenesis in humans as well, although further research is needed in this regard. This evidence concerns the gene NLRP3 and coronary artery disorder.